PEGylated Dendritic Architecture for Development of a Prolonged Drug Delivery System for an Antitubercular Drug

E-ISSN： 1875-5704|4|1|11-19

ISSN： 1567-2018

Source： Current Drug Delivery, Vol.4, Iss.1, 2007-01, pp. : 11-19

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Development of Biodegradable Drug Delivery System to Treat Addiction

By Mandal T.

Drug Development and Industrial Pharmacy, Vol. 25, Iss. 6, 1999-05 ,pp. : 773-779

Informa Healthcare

Access to resources Recommend Favorite

Development and evaluation of ocular drug delivery system

By Gorle Ashish Prakash Gattani S. G.

Pharmaceutical Development and Technology, Vol. 15, Iss. 1, 2010-02 ,pp. : 46-52

Informa Healthcare

Access to resources Recommend Favorite

Antitubercular Drug Development: Current Status and Research Strategies

Mini Reviews in Medicinal Chemistry, Vol. 13, Iss. 11, 2013-10 ,pp. : 1664-1684

Bentham Science Publishers

Access to resources Recommend Favorite

Drug delivery and targeting system

By Magnani M.

Expert Opinion on Therapeutic Targets, Vol. 2, Iss. 1, 1998-07 ,pp. : 145-146

Informa Healthcare

Access to resources Recommend Favorite

PEGylated non-ionic surfactant vesicles as drug delivery systems for Gambogenic acid

By Lin Tongyuan Fang Qingying Peng Daiyin Huang Xia Zhu Tingting Luo Qing Zhou Kai Chen Weidong

Drug Delivery, Vol. 20, Iss. 7, 2013-09 ,pp. : 277-284

Informa Healthcare

Access to resources Recommend Favorite